| Monin, Jean-Fabien (AC Immune 200901– CFO before 14y at bioMérieux CFO Central Europe) |
Chief Financial Officer (CFO) |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Monko, Michael (Sequenom 200608– Senior VP Sales + Marketing before UpState Chemicon before Invitrogen Corp) |
n. a. |
LabCorp (Group) |
United States (USA) |
| Monroe, Thomas Lawrence (Tom) (Actelion 201604 CEO of Vaxxilon AG) |
Chief Executive Officer (CEO) |
Idorsia (Group) |
Switzerland |
| Montag, Bernd (Siemens 201802 CEO of Siemens Healthineers) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Montagner, Carlo (200801– CEO + Founder of STA before Alchemia + Abraxas Bioscience et al + Schering 200510) |
Chief Executive Officer (CEO) |
Specialised Therapeutics Australia Pty Ltd. (STA) |
Australia |
| Montana, John (Charles River 201709– VP Integr Drug Discovery/Strategic Projects joined 2014 before Argenta+Paradigm) |
Business Development Manager / Strategy Manager |
Charles River (Group) |
United States (USA) |
| Montanari, Bruno (Omnes Capital 201607 Partner) |
Partner (venture partner) |
Omnes Capital S.A.S. |
France |
| Montenbruck, Ingo (Ingenium 200606 Senior Director BusDev) |
Business Development Manager / Strategy Manager |
Probiodrug (Group) |
Germany |
| Monz, Ludwin (Carl Zeiss 201401 CEO of Carl Zeiss Medictec AG) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
Germany |
| Moonen, Kees (Kreatech 200909– CEO before Green Cross Vaccine CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Moore, Jeffrey R. (Helicos 201208 SVP + CFO) |
Chief Financial Officer (CFO) |
Helicos BioSciences Corporation (Nasdaq: HLCS) |
United States (USA) |
| Moore, Kevin (Tecan 201011 Director Market and Application Management for BioPharma) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
| Mora, Luis (Zeltia 201208– Managing Director of newly founded Pharma Mar GmbH) |
Managing Director |
PharmaMar (Group) |
Germany |
| Morand, Olivier (Azafaros 201807– CEO before Idorsia + Actelion + Roche) |
Chief Executive Officer (CEO) |
Azafaros B.V. |
Netherlands |
| Moreno, Gerardo Cabanas (IPN 201203 Director of CMMN) |
Researcher (university / research institute) |
Instituto Politécnico Nacional (IPN) (National Polytechnic Institute, MX) |
Mexico |
| Morgan, Jeremy (Eli Lilly 201204 Managing Director of Lilly Deutschland GmbH) |
Managing Director |
Eli Lilly (Group) |
Germany |
| Morgenthaler, Nils (Bruker 201504 VP Medical Affairs at Bruker Daltonics division) |
n. a. |
Bruker Corporation (Group) |
United States (USA) |
| Morich, Frank (Takeda 201008– EVP International Operations before Noxxon CEO before Innogenetics + AM-Pharma + Bayer) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Japan |
| Morie, Brad (Biocrates 200805 VP Business Development LEFT before 10/11) |
Business Development Manager / Strategy Manager |
Biocrates (Group) |
Austria |
| Morlock, Gerda (Univ Giessen 201302 Professor) |
Professor |
University of Gießen (Justus Liebig University) |
Germany |
| Moro, Luigi (Cassiopea 201509 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
| Moroney, Simon E. (MorphoSys 1992– CEO + Founder) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Germany |
| Morrill, Paul (Horizon Discovery 201109 Commercial Director of reagents division) |
Chief Commercial Officer (CCO) |
Horizon Discovery (Group) |
United Kingdom (GB) |
| Morris, Andrew (SQI Diagnostics 201107 CFO) |
Chief Financial Officer (CFO) |
SQI Diagnostics Inc. |
Canada |
| Morris, David (Novartis 201804 Venture Partner at NVF) |
Partner (venture partner) |
Novartis (Group) |
Switzerland |
| Morris, Howard R. (M-Scan 1997– founder + Imperial College London Prof) |
Company Founder |
SGS (Group) |
United Kingdom (GB) |
| Morrison, Andrea (Merck (DE) 201204 Merck Serono International SA Antibodies Technologies) |
n. a. |
Merck (DE) (Group) |
Switzerland |
| Morrison, Jodie (Tokai Pharmaceuticals 201503 CEO) |
Chief Executive Officer (CEO) |
Tokai Pharmaceuticals, Inc. (Nasdaq: TKAI) |
United States (USA) |
| Morscher, Elmar (Integra Biosciences 200808 CEO) |
Chief Executive Officer (CEO) |
Integra Holding (Group) |
Switzerland |
| Moser, Christian (Pevion Biotech 201201 Head of Research) |
Research & Development Manager |
Pevion Biotech AG |
Switzerland |
| Moser, Markus (Prionics AG 201403 CEO) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
Switzerland |
| Moser, Thomas (Haplogen 201410 CEO) |
Chief Executive Officer (CEO) |
Haplogen Bioscience GmbH |
Austria |
| Moses, Edwin (Ablynx 200603– CEO before non-exec Board Member 200411– before Oxford Asymmetry) |
Chief Executive Officer (CEO) |
Ablynx (Group) |
Belgium |
| Moss, Jeremy (Roche 201207 Global Head of Point of Care at Roche Professional Diagnostics in Rotkreuz) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Most, Patrick (Inocard 201401– Managing Director + Co-founder) |
Managing Director |
Uniqure (Group) |
Germany |
| Mothes, Harald (Solvay 201108 Executive Board Director) |
Board member, executive |
Solvay (Group) |
Germany |
| Mothes, Helmut (Bayer Technology Services 200409) |
n. a. |
Bayer (Group) |
Germany |
| Motschmann, Michael (MIG Funds 200604) |
Investment Manager |
MIG Fonds (Group) |
Germany |
| Motz, Manfred (Mikrogen 2003) |
n. a. |
Mikrogen GmbH |
Germany |
| Mouney, Jean-François (Genfit 201204 CEO) |
Chief Executive Officer (CEO) |
Genfit (Group) |
France |
| Mous, Jan (Midatech 2010– CEO of PharMida AG before IntegraGen + Lion Bioscience + Roche) |
Chief Executive Officer (CEO) |
Midatech (Group) |
Switzerland |
| Mouz, Nicolas (PX'Therapeutics 201008– CEO of Promise Advanced Proteomics) |
Chief Executive Officer (CEO) |
Aguettant (Group) |
France |
| Mucke, Hermann (H.M. Pharma Consultancy) |
Consultant (economic/technology) |
H.M. Pharma Consultancy [Hermann Mucke Pharma Consultancy e.U.] |
Austria |
| Mucke, Lennart (Gladstone Institute 201006 Director) |
Professor |
Gladstone Institutes (Group) |
United States (USA) |
| Mudde, Geert C. (S-Target Therapeutics 201310 Managing Director + Co-founder) |
Managing Director |
S-Target Therapeutics GmbH |
Austria |
| Mueller, André J. (Addex 201106 Chairman of the Board before Actelion CFO before Biogen before Sandoz) |
Board member, non-executive |
Addex (Group) |
Switzerland |
| Mueller, Stefan (CureVac 201902– VP Preclinical before Sandoz Biopharmaceuticals + Merck Serono + Merck + Knoll GmbH) |
Research & Development Manager |
CureVac (Group) |
Germany |
| Muellershausen, Florian (Novartis 201902 Novartis Venture Fund) |
Investment Manager |
Novartis (Group) |
Switzerland |
| Muirhead, Gary (Ixchelsis Ltd 201308 CEO) |
Chief Executive Officer (CEO) |
Ixchelsis Ltd. |
United Kingdom (GB) |
| Mukhanov, Alexey (Nanohale 201110– Managing Director of RusNanohale) |
Managing Director |
Formycon (Group) |
Russian Federation |
| Mukherjee, Anindya (Direvo Industrial Biotech 200807– before DSM) |
n. a. |
Direvo Industrial Biotechnology (Group) |
Germany |
| Mukhopadhyay, Amal K. (ELGA Biotech 200905) |
n. a. |
ELGA Biotech (Hamburg) |
Germany |
| Mulet, Miguel (Genetrix 201207 Business Development Director before Janssen Pharmaceutica + co-founder of Mirada) |
Business Development Manager / Strategy Manager |
Genetrix (ES) (Group) |
Spain (España) |
| Muller, André C. (Idorsia 201706– CFO before Actelion 201309– CFO before Pierre Fabre CFO) |
Chief Financial Officer (CFO) |
Idorsia (Group) |
Switzerland |
| Muller, Christophe (Evotec 201411 VP Business Development) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
United Kingdom (GB) |
| Mummenbrauer, Torsten (Hookipa 201610–201904 SVP Bus Dev + Licensing before MorphoSys + GSK Vaccines LEFT 5/19) |
Business Development Manager / Strategy Manager |
Hookipa (Group) |
Austria |
| Munch, Mark R. (Bruker Corp 201407 President Bruker MAT Group before President Bruker Nano Surfaces Business) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
United States (USA) |
| Mund, Matthias (Dako Deutschland GmbH 200706 Managing Director) |
Managing Director |
Agilent (Group) |
Germany |
| Mundel, Trevor (Novartis 200805 Head Global Development Functions Novartis Pharma AG) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
| Muñoz, David (Pint Pharma 201607 CEO) |
Chief Executive Officer (CEO) |
Pint Pharma (Group) |
Switzerland |
| Munoz, Don (Noxxon Pharma 201409– CFO before Summer Street Research Partners + Cowen & Co + Leerink Swann) |
Chief Financial Officer (CFO) |
Noxxon (Group) |
United States (USA) |
| Muraca, Patrick J. (Nuclea Biotechnologies 201309 CEO) |
Chief Executive Officer (CEO) |
Nuclea Biotechnologies Inc. |
United States (USA) |
| Muralidhar, Bali (MVM Life Science Partners 201404 Partner) |
Partner (venture partner) |
MVM (Medical Venture Managers) (Group) |
United States (USA) |
| Murphy, Brian J. (Waters 200912 Public Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Waters (Group) |
United States (USA) |
| Murphy, David (Univ College Cork 201208 AquaTT Manager) |
General Manager (management) |
University College Cork (UCC) |
Ireland, Republic of |
| Murphy, Kieran (General Electric 201108 CEO GE Healthcare Life Sciences before Whatman 200701– CEO before Innovata) |
Chief Executive Officer (CEO) |
General Electric (Group) |
United Kingdom (GB) |
| Murphy, Sam (Salubri 201709 VP + Head of International Business Development) |
Business Development Manager / Strategy Manager |
Salubris (Group) |
China |
| Murray, Campbell (Novartis 201203 Managing Director of Novartis Venture Fund) |
Managing Director |
Novartis (Group) |
Switzerland |
| Murray, Neil (Redx Pharma 201112 CEO) |
Chief Executive Officer (CEO) |
Redx Pharma (Group) |
United Kingdom (GB) |
| Murray, Stephen (Affectis 201105– CMO befrore Memory Pharmaceuticals before Pfizer Pharmaceuticals) |
Chief Medical Officer (CMO) |
Affectis Pharmaceuticals AG |
Germany |
| Muster, Thomas (Blue Sky Vaccines 201509 CEO) |
Chief Executive Officer (CEO) |
Blue Sky Vaccines KG |
Austria |
| Mutel, Vincent (Addex 2002c–201106 CEO stepped down 6/11) |
Chief Executive Officer (CEO) |
Addex (Group) |
Switzerland |
| Muthian, Sean (Sigma-Aldrich 201501 Director of Global Stratetic Marketing + Partnerships) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
United States (USA) |
| Mutschler, Ernst (Univ Frankfurt Prof) |
Professor |
University of Frankfurt (Goethe-Universität) |
Germany |
| Mutter, Wolfgang (Hyglos 200903– Manager Director before Profos CEO before Roche Diagnostics GmbH Penzberg) |
Managing Director |
Mérieux (Group) |
Germany |
| Myers, Eugene W. (Max Planck 201206– Director of Max Planck Center for Systems Biology Dresden) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Myers, Jason (ArcherDx 2012– CEO + Co-founder before Ion Torrent) |
Chief Executive Officer (CEO) |
ArcherDX Inc. |
United States (USA) |
| Mühlenbeck, Frank (aeris Capital 200912 Partner before First Ventury Equity) |
Partner (venture partner) |
Aeris Capital AG |
Switzerland |
| Mühlenweg, Bernd (Nanobiotix 2011– Head Business Development before 2001–2011 Head BusDev at Wilex AG) |
Business Development Manager / Strategy Manager |
Nanobiotix (Group) |
France |
| Mühler, Andreas (Immunic 201604– CMO + Co-Founder) |
Chief Medical Officer (CMO) |
Immunic (Group) |
Germany |
| Mühlhaus, Axel (Edicto GmbH 201108 Managing Director + Owner) |
Managing Director |
Edicto GmbH |
Germany |
| Mylchreest, Iain (Thermo Fisher 201003 VP Life Sciences Mass Spectrometry) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
| Müller, Achim (EyeSense 201101 Managing Director) |
Managing Director |
EyeSense GmbH |
Germany |
| Müller, Alexander (Bruker 201512 Head Bruker Detection Division Defense Business) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
Germany |
| Müller, Andreas (Eurofins Scientific 201710– Managing Director at Institut Nehring GmbH) |
Managing Director |
Eurofins (Group) |
Germany |
| Müller, Anke |
n. a. |
Geneworx AG |
Germany |
| Müller, Barbara (Serva Electrophoresis GmbH 201308 Managing Director) |
Managing Director |
Serva Electrophoresis GmbH |
Germany |
| Müller, Claus (november AG 200705 Vorstandsvorsitzender) |
n. a. |
November (Group) |
Germany |
| Müller, Elfriede (TopLab GmbH 201002 Managing Director) |
Managing Director |
TopLab GmbH |
Germany |
| Müller, Emilia (Bavaria (govt) 200809 Minister of Economics) |
n. a. |
Bavaria (govt region) |
Germany |
| Müller, Gerhard (Gotham Therapeutics 201708– CSO before Mercachem BV + Proteros Fragments + Axxima + Organon + Bayer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Gotham Therapeutics (Group) |
Germany |
| Müller, Gerhard Anton (Univ Göttingen 201004 Professor Faculty of Medicine + 4/10 existent Advisory Board PANATecs) |
Professor |
University of Göttingen (Georg August University) |
Germany |
| Müller, Günter (MicroCoat Biotechnologie 201104 Managing Director) |
Managing Director |
MicroCoat Biotechnologie GmbH |
Germany |
| Müller, Hardy (Techniker Krankenkasse 201205 WINEG + Managing Director Aktionsbündnis Patientensicherheit) |
pharmacoeconomics |
Techniker Krankenkasse (Group) |
Germany |
| Müller, Holger (BlueSens Gas Sensor GmbH 201202 Managing Director) |
Managing Director |
BlueSens Gas Sensor GmbH |
Germany |
| Müller, Hubert (Fraunhofer PST 200407) |
n. a. |
Fraunhofer (Group) |
Germany |
| Müller, Jens-Peter (BRAIN AG 201812 Director Business Development + Project Managemet at AnaltiCon Discovery GmbH) |
Business Development Manager / Strategy Manager |
BRAIN (Group) |
Germany |
| Müller, Johannes (Berlin Cures 201409– CEO + Co-founder) |
Managing Director |
Berlin Cures (Group) |
Germany |
| Müller, Jörg (Coriolis Pharma 201206 before Protagen 201110– Head Marketing before M-Scan Office Munich) |
Sales Manager / Marketing Manager |
Coriolis Pharma (Group) |
Germany |
| Müller, Ludger (Putsch 201211 Managing Director of MP Beteiligungs-GmbH) |
Managing Director |
Putsch (Recaro) (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 39 40 41 ... 65 66 67 
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
